Corporate Translations

Validation of a Disease-Specific QoL Measure in Italian Patients with Systemic Lupus Erythematosus

Corporate Translations has contributed to a peer-reviewed manuscript on the validation of a disease-specific health-related quality of life measure in adult Italian patients with systemic lupus erythematosus: LupusQoL-IT.

This study assessed the validity of a linguistically validated version of the Lupus Quality of Life (LupusQoL©) questionnaire in Italian-speaking systemic lupus erythematosus (SLE) patients.

A new peer-reviewed study by Conti, et al., to which Corporate Translations is a contributor, entitled  Validation of a disease-specific health-related quality of life measure in adult Italian patients with systemic lupus erythematosus: LupusQoL-IT,  has been accepted for publication by the Lupus International Journal. The LupusQoL© is a 34-item Systemic Lupus Erythematosus (SLE) specific health-related quality of life (HRQoL) measure, consisting of eight domains: physical health, pain, planning, intimate relationships, burden to others, emotional health, body image, and fatigue. The study concluded that the Italian version of the LupusQoL© is a valid tool for use in adult patient populations with SLE.

The article can be accessed via Sage Publication Journals Online: http://lup.sagepub.com/content/early/2014/02/25/0961203314524466.abstract

More information on the LupusQoL©, including scoring, permissions and licensing, relevant research, and available translations is available at www.lupusqol.com

About Corporate Translations

Corporate Translations is a Certified Woman-Owned Business Enterprise that was founded in 1990 to specifically answer the demand for high quality translations solutions in the pharmaceutical, biotech, and medical device industries. With over 20 years of acquired knowledge in these highly regulated industries, the company has become a recognized expert in managing translation and linguistic validation projects for the world’s top pharmaceutical and biotech companies including Pfizer, Amgen, Eli Lilly, Novartis, and many more.

For more information about the company please call 860-727-6000 or visit www.corptransinc.com

Return to News and Updates
Promoted News and Updates